US Patent 9181322 Genetically modified human natural killer cell lines
Patent 9181322 was granted and assigned to Fox Chase Cancer Center (company) on November, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9181322 Genetically modified human natural killer cell lines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
